WuXi XDC Wuxi Hi-Tech District
Facility dedicated to the development and GMP manufacture of Antibody Drug Conjugates (ADCs) and other bioconjugates. Facility footprint encompasses nearly 6,000 square meters.
Site provides integrated services and solutions including process development, technology transfer, and pilot scale to large-scale cGMP production of drug substance and drug product.
State-of-the-art facility houses an advanced, fully-isolated automatic aseptic filling system which can fill 2R, 6R, 10R, 20R and 50R vials for either liquid or lyophilized products. With ability to provide three million doses annually, system provides the flexibility to meet production requirements for both global clinical trials and commercial product launch.
Site is part of WuXi XDC, a WuXi Biologics subsidary, that offers extensive and comprehensive set of in-house capabilities to handle all stages of ADC drug development, including development and manufacture of payload-linkers and antibody or other biological intermediates.